Anti-human IGFBP-5 antiserum is a polyclonal antiserum obtained from rabbits immunized with a synthetic peptide of unique sequence    corresponding to amino acids 154-168 (Zapf, J. (1995) Eur. J.    Endocrinol. 132, 645-654) from the central domain of human IGFBP-5.
This antiserum has been characterized for Enzyme Immunoassays (EIA).

     Quantity:                          100 µl of lyophilized serum.      Specificity:                          The antiserum is specific for human IGFBP-5. No                          crossreactivity is found with human IGFBPs                          (1,2,3,4,and -6).      Titre:                          Can be used at a dilution of 1/15,000 for EIA.                          Half-maximal inhibition (ED50) is produced by 30 ng                          hIGFBP-5 / 100µl. It is anticipated that the antiserum                          can be used at a dilution of 1/1,000 for Western                          blotting.      Reconstitution:                          Dissolve in 100 µl sterile water.      Storage/Stability:                          At least 2 years at 2 -4°C (lyophilized). After                          reconstitution, aliquot and store at -20°C or -80°C.                          Avoid repeated freezing and thawing.

 Datasheet for PAZ1 Anti-human IGFBP-5 Polyclonal Antiserum Specifications